GlaxoSmithKline LLC v. Sun Pharmaceutical Industries Ltd. - 1:25-cv-01170

GlaxoSmithKline LLC v. Sun Pharmaceutical Industries Ltd. (Case No. 1:25-cv-01170), filed on Sep 18, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-01170
Filing Date
Sep 18, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Sun Pharmaceutical Industries Ltd. -
Merck Sharp & Dohme LLC -
TESARO, Inc. -
GlaxoSmithKline LLC -

Patents Involved

This case involves 3 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US11673877B2
-US11091459B2
-US8071623B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.